Quarterly report pursuant to Section 13 or 15(d)

Investment in Derivative Instruments (Tables)

v3.24.1.1.u2
Investment in Derivative Instruments (Tables)
6 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivatives Instruments, Income Statement and Balance Sheet Classification
The following table represents the approximate amount of realized and unrealized gains (losses) and changes in fair value recognized in earnings on commodity derivative contracts for the three and six months ended March 31, 2024 and 2023 and the fair value of these derivatives as of March 31, 2024 and September 30, 2023 (in thousands):

For the Three Months Ended March 31,
2024 2023
(unaudited) (unaudited)
Change in Change in
Income Statement Classification Realized Gain (Loss) Unrealized Gain (Loss) Total Gain (Loss) Realized Gain (Loss) Unrealized Gain (Loss) Total Gain (Loss)
Cost of revenues $ (42) $ 32  $ (10) $ 456  $ (1,279) $ (823)
Interest expense, net 2,646  —  2,646  2,007  —  2,007 
Total $ 2,604  $ 32  $ 2,636  $ 2,463  $ (1,279) $ 1,184 

For the Six Months Ended March 31,
2024 2023
(unaudited) (unaudited)
Change in Change in
Income Statement Classification Realized Gain (Loss) Unrealized Gain (Loss) Total Gain (Loss) Realized Gain (Loss) Unrealized Gain (Loss) Total Gain (Loss)
Cost of revenues $ (61) $ (194) $ (255) $ 1,057  $ (2,286) $ (1,229)
Interest expense, net 5,284  —  5,284  3,342  —  3,342 
Total $ 5,223  $ (194) $ 5,029  $ 4,399  $ (2,286) $ 2,113 


March 31, 2024 September 30, 2023
Balance Sheet Classification (unaudited)
Prepaid expenses and other current assets - commodity swaps $ —  $ 204 
Other assets - interest rate swaps (1)
21,031  26,909 
Accrued expense and other current liabilities - commodity swaps (10) (20)
Net unrealized gain position $ 21,021  $ 27,093 
(1) Includes designated cash flow hedge of $21.0 million and $26.9 million as of March 31, 2024 and September 30, 2023, respectively.